2015 PhRMA Profile: Annual Membership Survey Results

PhRMA Principles on Interactions with Patient Organizations

PhRMA Chief Medical Officer and Executive Vice President William Chin

Dr. William W. Chin is the Chief Medical Officer and Executive Vice President at PhRMA beginning in July 2013. He leads the association’s continuing efforts in science advocacy in the drug discovery and development ecosystem.

PhRMA Executive Vice President Mit Spears

James M. (Mit) Spears is Executive Vice President and General Counsel of the Pharmaceutical Research and Manufacturers of America (PhRMA). Mr. Spears oversees the Legal Department and also serves as a member of the PhRMA Management Committee.

PhRMA Executive Vice President Lori Reilly

Lori M. Reilly is Vice-President for Policy & Research at the Pharmaceutical Research and Manufacturers of America (PhRMA). Her primary focus is overseeing development of legislative and policy analysis and research studies on a range of health care issues.

PhRMA Executive Vice President Paul Aines

Paul Aines is Executive Vice President, Administration, and Chief Financial Officer at PhRMA. He is responsible for budgeting and finance operations, IT services, human resources, facilities and Rx Response.

PhRMA Executive Vice President Chip Davis

Chester “Chip” Davis, Jr. is the Executive Vice President for Advocacy and Member Relations at PhRMA. He leads PhRMA’s federal, state and international government relations and advocacy efforts, and is responsible for membership recruitment and retention.

PhRMA Executive Vice President Josie Martin

Josie Martin is Executive Vice President of Public Affairs for PhRMA. She leads communications and alliance development functions.

The Power of Knowledge

01.24.14 | By

Nelson Mandela once said, “Education is the most powerful weapon which you can use to change the world.” This statement couldn't be more accurate. With scientists and researchers in the biopharmaceutical industry constantly learning about diseases and working toward discovering new treatments for patients that could have a profound impact on our society, it is increasingly important to ensure we’re also developing the next generation of scientists.


PhRMA Operational Status for Monday, March 3: CLOSED

Site will be updated only with a change of status.


Subscribe to RSS - About